USD 0.04
(0.25%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 242.64 Thousand USD | 322.78% |
2022 | 57.39 Thousand USD | -49.58% |
2021 | 113.83 Thousand USD | -59.25% |
2020 | 279.36 Thousand USD | 313.22% |
2019 | 67.6 Thousand USD | 584.41% |
2018 | 9878.00 USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | -100.0% |
2015 | 9396.00 USD | -98.6% |
2014 | 670.27 Thousand USD | -11.87% |
2013 | 760.52 Thousand USD | 4.94% |
2012 | 724.71 Thousand USD | -76.12% |
2011 | 3.03 Million USD | -0.84% |
2010 | 3.06 Million USD | -0.83% |
2009 | 3.08 Million USD | 59.54% |
2008 | 1.93 Million USD | 134.05% |
2007 | 826.44 Thousand USD | 932.29% |
2006 | 80.05 Thousand USD | 0.0% |
2005 | - USD | -100.0% |
2004 | 269.03 Thousand USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 228.66 Thousand USD | -5.76% |
2024 Q2 | 213.76 Thousand USD | -6.52% |
2023 FY | 242.64 Thousand USD | 322.78% |
2023 Q4 | 242.64 Thousand USD | -4.34% |
2023 Q3 | 253.65 Thousand USD | 847.89% |
2023 Q1 | 42.24 Thousand USD | -26.39% |
2023 Q2 | 26.76 Thousand USD | -36.66% |
2022 Q3 | 72.06 Thousand USD | -16.6% |
2022 Q1 | 100.27 Thousand USD | -11.91% |
2022 Q4 | 57.39 Thousand USD | -20.35% |
2022 FY | 57.39 Thousand USD | -49.58% |
2022 Q2 | 86.39 Thousand USD | -13.84% |
2021 Q2 | 139.78 Thousand USD | -9.26% |
2021 Q1 | 154.05 Thousand USD | -44.85% |
2021 FY | 113.83 Thousand USD | -59.25% |
2021 Q4 | 113.83 Thousand USD | -10.34% |
2021 Q3 | 126.96 Thousand USD | -9.17% |
2020 FY | 279.36 Thousand USD | 313.22% |
2020 Q1 | - USD | -100.0% |
2020 Q4 | 279.36 Thousand USD | 0.0% |
2019 Q4 | 67.6 Thousand USD | -4.31% |
2019 FY | 67.6 Thousand USD | 584.41% |
2019 Q3 | 70.65 Thousand USD | -12.56% |
2019 Q2 | 80.79 Thousand USD | -13.8% |
2019 Q1 | 93.73 Thousand USD | 848.88% |
2018 Q3 | 10.17 Thousand USD | -5.33% |
2018 Q4 | 9878.00 USD | -2.94% |
2018 FY | 9878.00 USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 Q2 | 10.75 Thousand USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2016 FY | - USD | -100.0% |
2016 Q4 | - USD | -100.0% |
2016 Q2 | 3883.00 USD | -40.88% |
2016 Q1 | 6568.00 USD | -30.1% |
2016 Q3 | 938.00 USD | -75.84% |
2015 Q4 | 9396.00 USD | -23.07% |
2015 FY | 9396.00 USD | -98.6% |
2015 Q3 | 12.21 Thousand USD | -18.52% |
2015 Q2 | 14.99 Thousand USD | -97.75% |
2015 Q1 | 667.57 Thousand USD | -0.4% |
2014 Q4 | 670.27 Thousand USD | -10.98% |
2014 Q3 | 752.93 Thousand USD | -0.35% |
2014 FY | 670.27 Thousand USD | -11.87% |
2014 Q2 | 755.55 Thousand USD | -0.32% |
2014 Q1 | 757.98 Thousand USD | -0.33% |
2013 FY | 760.52 Thousand USD | 4.94% |
2013 Q4 | 760.52 Thousand USD | 8.35% |
2013 Q3 | 701.92 Thousand USD | -2.98% |
2013 Q2 | 723.5 Thousand USD | -0.37% |
2013 Q1 | 726.17 Thousand USD | 0.2% |
2012 FY | 724.71 Thousand USD | -76.12% |
2012 Q2 | 3.02 Million USD | -0.12% |
2012 Q1 | 3.03 Million USD | -0.14% |
2012 Q3 | 766.8 Thousand USD | -74.67% |
2012 Q4 | 724.71 Thousand USD | -5.49% |
2011 Q1 | 3.05 Million USD | -0.21% |
2011 Q3 | 3.04 Million USD | -0.22% |
2011 Q2 | 3.04 Million USD | -0.21% |
2011 FY | 3.03 Million USD | -0.84% |
2011 Q4 | 3.03 Million USD | -0.19% |
2010 Q1 | 3.07 Million USD | -0.2% |
2010 Q4 | 3.06 Million USD | -0.98% |
2010 FY | 3.06 Million USD | -0.83% |
2010 Q3 | 3.09 Million USD | -0.04% |
2010 Q2 | 3.09 Million USD | 0.4% |
2009 Q3 | 3.09 Million USD | -1.81% |
2009 Q2 | 3.15 Million USD | 40.98% |
2009 Q1 | 2.23 Million USD | 15.76% |
2009 FY | 3.08 Million USD | 59.54% |
2009 Q4 | 3.08 Million USD | -0.44% |
2008 FY | 1.93 Million USD | 134.05% |
2008 Q3 | 172.39 Thousand USD | -86.62% |
2008 Q2 | 1.28 Million USD | 20.76% |
2008 Q1 | 1.06 Million USD | 29.14% |
2008 Q4 | 1.93 Million USD | 1021.99% |
2007 Q2 | 246.6 Thousand USD | 233.95% |
2007 Q4 | 826.44 Thousand USD | 104.06% |
2007 FY | 826.44 Thousand USD | 932.29% |
2007 Q3 | 405 Thousand USD | 64.23% |
2007 Q1 | 73.84 Thousand USD | -7.76% |
2006 Q2 | 262.23 Thousand USD | 0.0% |
2006 Q3 | 303.76 Thousand USD | 15.84% |
2006 Q4 | 80.05 Thousand USD | -73.64% |
2006 Q1 | - USD | 0.0% |
2006 FY | 80.05 Thousand USD | 0.0% |
2005 FY | - USD | -100.0% |
2005 Q3 | - USD | -100.0% |
2005 Q1 | 269.01 Thousand USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2005 Q2 | 269.01 Thousand USD | 0.0% |
2004 FY | 269.03 Thousand USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
American Medical Technologies Inc. | 500 Thousand USD | 51.471% |
Ansell Limited | 855.59 Million USD | 99.972% |
Ansell Limited | 857.2 Million USD | 99.972% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | 22.41 Million USD | 98.917% |
BioLife Sciences Inc. | - USD | -Infinity% |
CB Scientific, Inc. | 20.93 Thousand USD | -1059.035% |
Psykey, Inc. | 1.01 Million USD | 75.99% |
ConvaTec Group Plc | 1.31 Billion USD | 99.981% |
ConvaTec Group Plc | 1.31 Billion USD | 99.982% |
Encision Inc. | 1.33 Million USD | 81.8% |
Golden Valley Development, Inc | - USD | -Infinity% |
Hear AtLast Holdings, Inc. | 2.3 Million USD | 89.49% |
Innovative MedTech Inc. | 1.87 Million USD | 87.081% |
LifePoint, Inc. | 446.74 Thousand USD | 45.686% |
Medite Cancer Diagnostics, Inc. | 5.39 Million USD | 95.502% |
Paradigm Medical Industries, Inc. | 2.18 Million USD | 88.915% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | - USD | -Infinity% |
SmileDirectClub, Inc. | 871.79 Million USD | 99.972% |
Sector 10, Inc. | 164 Thousand USD | -47.954% |
Shandong Weigao Group Medical Polymer Company Limited | 674.01 Million USD | 99.964% |
SheerVision, Inc. | 75 Thousand USD | -223.525% |
United Health Products, Inc. | 755.98 Thousand USD | 67.904% |
Vasamed, Inc. | 23.45 Thousand USD | -934.729% |
Wearable Health Solutions, Inc. | 2.76 Million USD | 91.232% |
Yubo International Biotech Limited | 790.49 Thousand USD | 69.305% |